Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: A community practice experience

被引：6
|
作者：
Shen, Huafeng [1 ]
Lipka, Seth [2 ]
Katz, Seymour [3 ,4 ,5 ]
机构：
[1] Nassau Univ, Med Ctr, Dept Med, E Meadow, NY USA
[2] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33612 USA
[3] NYU, Sch Med, New York, NY USA
[4] North Shore Univ Hosp Ong Isl Jewish Hlth Syst, Manhasset, NY USA
[5] St Francis Hosp, Roslyn, NY USA
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷 / 08期
关键词：
D O I：
10.1016/j.crohns.2013.12.016
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：898 / 899
页数：2
相关论文
共 50 条
  • [21] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Calloway, Alexis
    Dalal, Robin
    Beaulieu, Dawn B.
    Duley, Caroline
    Annis, Kimberly
    Gaines, Lawrence
    Slaughter, Chris
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567
  • [22] The role of anti-tumor necrosis factor-α therapy in Pyoderma gangrenosum associated with inflammatory bowel disease
    Reguiai, Ziad
    Grange, Florent
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (02) : 67 - 77
  • [23] Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease in the Setting of Immunosuppression for Solid Organ Transplantation
    El-Nachef, Najwa
    Terdiman, Jonathan
    Mahadevan, Uma
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1210 - 1211
  • [24] Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 769 - 777
  • [25] Pulmonary lesions in patients with inflammatory bowel disease - the baseline and under anti-tumor necrosis factor therapy
    Borisov, Sergey
    Frolova, Ksenia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [26] The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease
    Ziad Reguiaï
    Florent Grange
    American Journal of Clinical Dermatology, 2007, 8 : 67 - 77
  • [27] Benefits and Risks of Combining Anti-tumor Necrosis Factor with Immunomodulator Therapy in Pediatric Inflammatory Bowel Disease
    Cozijnsen, Martinus A.
    Escher, Johanna C.
    Griffiths, Anne
    Turner, Dan
    de Ridder, Lissy
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (04) : 951 - 961
  • [28] Anti-Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women With Inflammatory Bowel Disease
    Cho, Yongtai
    Choi, Eun-Young
    Choi, Ahhyung
    Han, Jung Yeol
    Ye, Byong Duk
    Kim, Ju Hwan
    Shin, Ju-Young
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 241 - 250
  • [29] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Alexis Calloway
    Robin Dalal
    Dawn B. Beaulieu
    Caroline Duley
    Kimberly Annis
    Lawrence Gaines
    Chris Slaughter
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
  • [30] Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Reply
    Bouguen, Guillaume
    Brunet, Tanguy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 855 - 856
12345